Eye-scanning device is designed to detect Alzheimer's disease

07/16/2013 | American City Business Journals

Cognoptix has created a noninvasive eye-scanning device, called SAPPHIRE II, that uses a specific beta amyloid signature in the eye to determine whether a patient is at risk for Alzheimer's disease. The Acton, Mass.-based company will release information on the device Wednesday at a conference in Boston.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC